🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial
🌟 Hiddo Heerspink on finerenone in FSGS (FIND-CKD): see albuminuria and proteinuria 🔎
👉 https://journals.lww.com/jasn/pdf/10.1681/asn.0000001333~finerenone-in-patients-with-focal-segmental
tobias-b-huber.bsky.social
#ISGDCTS2026 #ISGD #GlomerularDisease #ClinicalTrial
Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy: A Scoping Review
https://pubmed.ncbi.nlm.nih.gov/43019564/
Implementation Strategies to Improve CKD Testing and Delivery of Guideline-Directed Medical Therapy: A Scoping Review
https://pubmed.ncbi.nlm.nih.gov/43019564/
As CKD progresses, benefits & harms may shift.
STOP-ACEi challenged assumptions about stopping RAAS inhibitors in advanced CKD.
📑 A #JASN article highlights why randomized discontinuation trials matter.
🔗 journals.lww.com/jasn/pdf/10....
As CKD progresses, benefits & harms may shift.
STOP-ACEi challenged assumptions about stopping RAAS inhibitors in advanced CKD.
📑 A #JASN article highlights why randomized discontinuation trials matter.
🔗 journals.lww.com/jasn/pdf/10....
- SGLT2i in a Mouse Model of ANCA-Associated Vasculitis
- Pregnancy and CKD Progression in ADPKD
- and more
kidney.pub/JASN-1126
#ASNJASN
- SGLT2i in a Mouse Model of ANCA-Associated Vasculitis
- Pregnancy and CKD Progression in ADPKD
- and more
kidney.pub/JASN-1126
#ASNJASN
n1info.ba/vijesti/jasn...
n1info.ba/vijesti/jasn...
Samo jaz je ne bom diskreditiro 😇
Samo jaz je ne bom diskreditiro 😇
🔬 Larger trials needed.
🔗 www.ovid.com/jnls/jasn/fu...
🔬 Larger trials needed.
🔗 www.ovid.com/jnls/jasn/fu...
journals.lww.com/jasn/abstrac... in @asnpublications.bsky.social #JASN
ADPKD has been excluded from flozins trials (concern about cyst growth) - and this pilot trial does show that
VA by @edgarvlermamd.medsky.network
journals.lww.com/jasn/abstrac... in @asnpublications.bsky.social #JASN
ADPKD has been excluded from flozins trials (concern about cyst growth) - and this pilot trial does show that
VA by @edgarvlermamd.medsky.network
Upacicalcet in HD - IV formulation reduces PTH
journals.lww.com/jasn/fulltex...
With VA from @edgarvlermamd.medsky.network
Upacicalcet in HD - IV formulation reduces PTH
journals.lww.com/jasn/fulltex...
With VA from @edgarvlermamd.medsky.network
vascular access survival trends in JASN @asnpublications.bsky.social
journals.lww.com/jasn/abstrac...
#KidneyWk
vascular access survival trends in JASN @asnpublications.bsky.social
journals.lww.com/jasn/abstrac...
#KidneyWk
pubmed.ncbi.nlm.nih.gov/42319856/
#KidneyWk
pubmed.ncbi.nlm.nih.gov/42319856/
#KidneyWk
kidney.pub/bestofses...
kidney.pub/bestofses...
#Nephpearls #VascularAccessPearls #KidneyWk #NephSky
👉 journals.lww.com/jasn/fulltex...
#Nephpearls #VascularAccessPearls #KidneyWk #NephSky
👉 journals.lww.com/jasn/fulltex...